Corporate Advisory Council


Nancy Bayerlein
Director, Patient Engagement and Support
Mitsubishi Tanabe Pharma America, Inc.

Todd Bledsoe
Associate Director, Patient Engagement and Advocacy
Neurocrine Biosciences, Inc.

Ann Marie Dawidczyk
US Health Policy & Reimbursement Strategy
GE Healthcare

Jessica DiPaolo
Director, Patient Advocacy & Strategic Alliances
Novartis Pharmaceuticals Corporation

Liz Hanpeter
Director, Therapeutic Area Policy and Advocacy
Takeda Pharmaceuticals America, Inc.

Christina G. Hochul, JD, LLM
Director of Strategic Alliances & Advocacy
U.S. Public Policy & Government Affairs

Lisa Hughes
Director, Alliance Advocacy
Allergan, Plc.

Craig Kramer
Chair, External Affairs – Mental Health Ambassador
Janssen Research & Development, LLC

Stephen Scango
Director of Federal Government Affairs
Abbvie, Inc.

Chris Sherwood
Director, Global Advocacy Relations

Melissa Stevens
Senior Brand Manager
Teva Pharmaceuticals

Heather Strawn
Vice President, Government Affairs
Lundbeck Pharmaceuticals LLC

Deborah Walter
Head of Office
Greenwich Biosciences



The American Brain Coalition (ABC) is a unique non-profit membership organization drawn from patients, researchers, clinicians, universities, government agencies, and corporations devoted to informing Congress, the Executive Branch and the public of the impact that brain research has on the lives of real citizens. Together, we raise awareness among policymakers about the cause, impact, and consequences of neurologic, including psychiatric, illness in society through education and advocacy on cutting edge developments in brain research.

Corporate members within the ABC are comprised of leading companies who recognize the importance of partnering with those committed to helping people with brain diseases and disorders. Corporate members include pharmaceutical, biotech, and medical device companies that are developing or marketing therapeutic or diagnostic products.

ABC corporate members may designate one individual to represent them on the ABC’s Corporate Advisory Council[i] (CAC). The Council provides unique opportunities for companies to engage with experts in the brain disease community, not only with patient advocacy organizations, but also with top scientific, clinical and policy experts and leaders in the worldwide central nervous system space.


ABC Corporate Advisory Council Members are encouraged to:

Participate in two Corporate Advisory Council Meetings each year, with access to ABC’s leaders in the central nervous system community

Participate in ABC’s yearly Board of Directors in-person breakfast, lunch, or dinner

Participate in ABC’s annual Membership Meeting, involving lively discussion, program presentations, and policy updates

Provide your company’s logo, web site links, and materials for special recognition under the Corporate Members, Industry Partner Highlight, Calendar, and Resources sections of the ABC’s web site  

Circulate CNS-related articles and events from your company to the ABC membership through our bi-weekly newsletters and social media sites

Review and share with your company the ABC’s newsletter including articles and events from the ABC membership, brain-related policy alerts, and government agency reports

Partnership and network with the ABC’s diverse membership of brain-related patient advocacy groups, professional organizations, researchers and clinicians

Approved: September 30, 2019

[i] The American Brain Coalition acts in accordance with the Federal Advisory Committee Act, the legal foundation defining how federal advisory committees operate. The law has special emphasis on open meetings, chartering, public involvement, and reporting. 


American Brain Coalition

P.O. Box 1549 | Maple Grove, MN 55311 | Phone: (763) 516-3583